Insights

Innovative Pipeline Cullinan Therapeutics has built a diversified portfolio of clinical-stage assets targeting oncology and autoimmune diseases, presenting multiple opportunities to collaborate on emerging therapies with hospital networks and specialty clinics focusing on cancer treatment and autoimmune disorder management.

Strategic Partnerships Recent collaborations, including licensing agreements for velinotamig and partnerships with Genrix Bio, indicate an openness to strategic alliances, creating potential sales channels for novel biotherapeutics within biotech and pharma industry partners.

Event Engagement Active participation in prominent industry events such as ASH, ASCO, and investor forums suggests ongoing outreach and visibility efforts, making these platforms ideal for engaging with decision-makers seeking innovative treatment solutions.

Financial Growth With revenue between 50 and 100 million dollars and recent funding activities, Cullinan Therapeutics is in a growth phase, providing opportunities for sales of advanced therapies, research services, and partnership collaborations supported by its financial stability.

Tech-Driven Approach Utilization of advanced tech stack including AWS, Workato, and Confluence indicates a focus on innovation and efficiency, aligning with potential enterprise-level data integration and automation solutions that could enhance their research and development capabilities.

Cullinan Therapeutics Tech Stack

Cullinan Therapeutics uses 8 technology products and services including Level Access, Amazon Web Services, Workato, and more. Explore Cullinan Therapeutics's tech stack below.

  • Level Access
    Accessibility
  • Amazon Web Services
    Cloud Hosting
  • Workato
    Data Integration
  • Font Awesome
    Font Scripts
  • Slick
    Javascript Libraries
  • Adobe Acrobat DC
    Rich Text Editors
  • Adobe Creative Suite
    Visualisation Software
  • Atlassian Confluence
    Wikis

Media & News

Cullinan Therapeutics's Email Address Formats

Cullinan Therapeutics uses at least 2 format(s):
Cullinan Therapeutics Email FormatsExamplePercentage
FLast@cullinanoncology.comJDoe@cullinanoncology.com
92%
Last@cullinanoncology.comDoe@cullinanoncology.com
5%
FMiddleLast@cullinanoncology.comJMichaelDoe@cullinanoncology.com
1%
First.Last@cullinanoncology.comJohn.Doe@cullinanoncology.com
1%
F.Last@cullinanoncology.comJ.Doe@cullinanoncology.com
1%

Frequently Asked Questions

Where is Cullinan Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Cullinan Therapeutics's main headquarters is located at 1 Main St, Cambridge, Massachusetts 02142, US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Cullinan Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Cullinan Therapeutics is a publicly traded company; the company's stock symbol is CGEM.

What is Cullinan Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Cullinan Therapeutics's official website is cullinantherapeutics.com and has social profiles on LinkedIn.

What is Cullinan Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Cullinan Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cullinan Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2025, Cullinan Therapeutics has approximately 138 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer: J. J.Chief Technical Operations Officer: K. J.Chief Scientific Officer: J. M.. Explore Cullinan Therapeutics's employee directory with LeadIQ.

What industry does Cullinan Therapeutics belong to?

Minus sign iconPlus sign icon
Cullinan Therapeutics operates in the Biotechnology Research industry.

What technology does Cullinan Therapeutics use?

Minus sign iconPlus sign icon
Cullinan Therapeutics's tech stack includes Level AccessAmazon Web ServicesWorkatoFont AwesomeSlickAdobe Acrobat DCAdobe Creative SuiteAtlassian Confluence.

What is Cullinan Therapeutics's email format?

Minus sign iconPlus sign icon
Cullinan Therapeutics's email format typically follows the pattern of FLast@cullinanoncology.com. Find more Cullinan Therapeutics email formats with LeadIQ.
Cullinan Therapeutics

Cullinan Therapeutics

Biotechnology ResearchUnited States51-200 Employees

Cullinan Therapeutics is dedicated to creating new standards of care for patients. 
 
We have strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Our portfolio encompasses a wide range of modalities, each with the potential to be best and/or first in class.  

Anchored in a deep understanding of oncology, immunology, and translational medicine, we create differentiated ideas, identify the most appropriate targets, and select the optimal modality to develop transformative therapeutics across a wide variety of cancer and autoimmune indications.

Notice to Job Seekers: Job applicants should be aware of job recruitment, interview and offer scams being perpetrated through the use of the internet and social media platforms. To learn more, visit our Careers page or read Cullinan’s Employment Recruitment Scams Notice here: https://cullinantherapeutics.com/docs/employment-recruitment-scams-notice.pdf

Section iconCompany Overview

Headquarters
1 Main St, Cambridge, Massachusetts 02142, US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CGEM
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $50M$100M

    Cullinan Therapeutics's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Cullinan Therapeutics's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.